Back

Where are we heading? factor XI inhibitors for atrial fibrillation and stroke prevention

8 April 2024 (16:00 - 16:15)
Organised by: Logo
Congress Presentation Part of: Are we seeing a paradigm shift in anticoagulation? NOACs and factor XIa inhibitors European Heart Rhythm Association (EHRA) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Jean-Claude Deharo

Hospital La Timone of Marseille, Marseille (France)

3 More presentations in this session

Presentation thumbnail
Where we are now? balancing stroke and bleeding in atrial fibrillation
Professor G. Lip (Liverpool, GB)
Slides
Presentation thumbnail
Why now? mechanistically comparing factor XI inhibitors with NOACs
Professor V. Roldan-Schilling (Murcia, ES)
Slides
Presentation thumbnail
What about holistic or integrated care management for atrial fibrillation?
Associate Professor M. Proietti (Milan, IT)
Slides

Access the full session

Session thumbnail
Are we seeing a paradigm shift in anticoagulation? NOACs and factor XIa inhibitors

The Event

Event poster

EHRA 2024

8 April 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Factor XI inhibitors or direct oral anticoagulants in atrial fibrillation: an updated meta-analysis
1 September 2025
thumbnail
Congress Presentation
Atrial fibrillation in a patient with hemophilia B
25 August 2023
thumbnail
Congress Presentation
Prior anticoagulation experience, bleeding risk, and safety of factor XI inhibition in atrial fibrillation: an analysis of AZALEA-TIMI 71
1 September 2025
thumbnail
Congress Presentation
Valvular presence of coagulation factor XI correlates with the severity of aortic stenosis
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources